Company Overview

Liontown (ASX: LTR) is a Western Australian lithium producer. The company has moved from developer to operator with its Kathleen Valley project, which began producing spodumene concentrate in 2024 and is now in the middle of a transition from open-pit to underground mining. With shares down by more than half this year, the stock is one of the sector's most closely watched names.

Read our earlier coverage of Liontown's journey from construction to production.

Business Segments & Field of Activity

Liontown's activities centre on two areas:

Lithium Mining: Kathleen Valley, where underground ore has become the main source of feed

Processing and Sales: production of spodumene concentrate, shipped through the Port of Geraldton to battery supply chain customers

Its key developments include:

Underground Ramp-Up: underground ore made up 58% of ore mined in FY26, with a target run rate of 2.8 million tonnes per annum by the end of FY27.
Kathleen Valley Expansion: a board-approved project to lift concentrate capacity by about 56% to 780,000 tonnes per annum.

From Cash Preservation to Reinvestment

FY26 marked a turning point for the balance sheet. Revenue more than doubled to $639 million, and the company reported its first underlying profit from Kathleen Valley of $14 million, on underlying EBITDA of $147 million. Statutory net profit was $93 million, but that figure included $113 million from recognising carry-forward tax losses, so it overstates the operating result. Liontown moved from net debt of $567 million to net cash of $192 million, helped by the conversion of LG Energy Solution's convertible note in February, which cut debt by $353 million, and ended June with cash of $561 million. Production for the year was about 392,000 tonnes of concentrate, against 382,000 tonnes shipped.

The $389 Million Expansion Decision

On 30 September, the board approved the Kathleen Valley expansion, which is expected to lift capacity to 780,000 tonnes per annum by early FY2030. Management puts the capital cost at roughly $389 million, or about $1,619 per tonne of added capacity, with an estimated payback of 2.5 years, and says it can be funded from existing cash and operating cash flow. FY27 capital spending guidance has been lifted to $435 million to $495 million to include the project. The decision accelerates the move to underground mining and positions Liontown to add supply at a point when the lithium market is still weak.

Costs Rise Before They Fall

The market's reaction to the guidance has been cool, because FY27 unit operating costs are forecast at $1,050 to $1,250 per tonne, up from about $985 in FY26, as the underground transition adds expense. Management expects costs to fall to $840 to $920 per tonne once the expanded operation is at full rate. Concentrate production is guided at 390,000 to 440,000 tonnes for FY27, and early shipments may be deferred by planned maintenance and surge events at Geraldton port. Plant recovery averaged 63% in the June quarter and improved when feed from underground was more consistent.

Why Lithium Stocks Are Under Pressure?

Lithium prices have retreated sharply. On 12 October the Guangzhou lithium carbonate contract fell 10% to 104,740 yuan per tonne, roughly half its May peak, and spodumene concentrate fell 12.4% to about US$1,485 per tonne. Analysts describe the sell-off as an expectations trade, with attention on returning supply and softer demand forecasts for 2027. An EU-China agreement caps Chinese hybrid vehicle imports below the current run rate, China plans to cut its export VAT rebate for new energy vehicles from April 2027, and China's new energy vehicle retail sales fell 12% in September. On the supply side, CATL's Jianxiawo mine has restarted its approval process, and mines such as Bald Hill and Finniss are returning.

Shares Slide Toward the Placement Price

LTR fell 5.6% to $0.68 on volume of about 44.6 million, slightly above the average of around 40 million, and today's low of $0.667 is also the lowest level of the past year. The shares are down by more than half since May, and attempts to rally have stalled near $0.73 to $0.80, close to the price of the August 2025 equity raising, which now acts as overhead supply. Analyst consensus targets of $1.20 to $1.39 sit well above the current price, but they depend on a recovery in lithium prices. At $0.68 the company has a market value of about $2.3 billion.

Risks Behind the Sell-Off

Liontown's earnings remain highly sensitive to lithium prices and a further decline would compress margins at a time when unit costs are rising. The expansion adds execution risk, including the delivery of the underground ramp-up and the tie-in of new plant while production continues. With plant recovery at 63%, operational improvement is still needed to reach the targets, and further supply returning to the market could keep prices under pressure. Short selling has also been reported near $0.80, which can add to volatility around resistance.

Important Disclaimer: You’re reading a free article that offers general opinions and insights. For exclusive, in-depth research, timely high-conviction investment ideas, and actionable trade signals designed to help you stay ahead, join Proactive Equities today by opening a Free Basic Account now! (No Credit Card Required)

Technical Analysis of Liontown (ASX: LTR)

Source: TradingView

On the weekly timeframe, the dominant trend for LTR remains bearish. In our previous analysis, we noted the break below the $1.33 to $1.36 floor and flagged the $0.79 to $0.82 zone as the major support, and that last support has now been lost. The next support sits around $0.055 to $0.060, and with the RSI approaching oversold territory, the reading reflects the intensity of the selling rather than a confirmed reversal signal.

FAQs about Liontown (ASX: LTR)

1. What does Liontown actually sell, and why does its price matter?

Liontown sells spodumene concentrate, a lithium-bearing product at around 5% lithium oxide that is refined into the lithium chemicals used in electric vehicle batteries. Because it sells the raw concentrate rather than finished chemicals, its revenue moves closely with spodumene prices.

2. What is the Kathleen Valley expansion?

The board approved it on 30 September to lift concentrate capacity by about 56% to 780,000 tonnes per annum by early FY2030, funded from existing cash and operating cash flow.

3. Does Liontown pay a dividend?

No. The company pays no dividend and is directing its cash toward the underground ramp-up and the Kathleen Valley expansion.

Company Over​view